Enzymit
PrivateLast Round
Series A
Sep 25, 2024
Total Funding Raised
$15M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Enzymit operates in Healthcare & Life Sciences and is based in Ness Ziona. Its latest recorded funding round was a Series A round in September 2024.
Enzymit is a biotechnology company that develops a cell-free bioproduction platform using AI-driven computational enzyme design to create novel enzymes for sustainable manufacturing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clean Manufacturing, Sustainable Materials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Enzymit Comparables
Compare Enzymit with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EnginZyme | 85% | |
| Debut | 83% | |
| Zymvol Biomodeling | 82% |
For institutional investors. Book with your work email.
Enzymit Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 25, 2024 | ||||
| Seed | Apr 6, 2022 | ||||
| Pre Seed | Jul 1, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Enzymit Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Khosla Ventures | Series A |
| Grove Ventures | Series A |
| First Star Ventures | Series A, Seed |
| NextLeap Ventures | Seed |
| Sapir Venture Partners | Series A, Seed, Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 95% MoM.
- Nov 10, 2025
Launched a cell-free biomanufacturing approach using AI-designed enzymes.
For institutional investors. Book with your work email.
Enzymit Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Enzymit's valuation, stock price, and market status.
Is Enzymit a public or private company?
Enzymit is a private company.
What is the current stock price of Enzymit?
Enzymit is a private company, so its shares have no public market price. Caplight tracks Enzymit's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Enzymit worth (valuation)?
Valuation information for Enzymit is not publicly available.
Can I buy Enzymit stock?
Enzymit shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Enzymit's last funding round?
Enzymit's most recent funding round was Series A on September 25, 2024.
Who are the main investors in Enzymit?
Key investors in Enzymit include Khosla Ventures, Grove Ventures, First Star Ventures, Sapir Venture Partners.
Will Enzymit IPO soon?
No public IPO plans have been announced for Enzymit.
How can I track Enzymit secondary market activity?
Caplight tracks bids, offers, and trades in Enzymit's shares on secondary markets.